SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)
KG 23.52-4.6%Oct 29 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gregor who wrote (34)9/3/2000 10:37:24 AM
From: babette spatz  Read Replies (1) of 61
 
O.K. JMED was awash with cash. KG has big debts. Now that more money is available, will it return to a negative cash position. Also, JMED grew by acquisition. What is KG's plan? If the democrats have their way, most pharmaceutical
companies will suffer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext